BioCorRx Inc. BICX
$0.25
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -50.62% | 59.01% | -- | -- | 4,355.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -50.62% | 59.01% | -- | -- | 4,355.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -131.99% | 40.40% | -- | -- | 4,355.00% |
| SG&A Expenses | -43.90% | -12.48% | -35.72% | -3.98% | 47.33% |
| Depreciation & Amortization | -86.39% | -54.84% | -1,060.00% | 974.63% | 974.63% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.43% | 8.52% | -65.94% | 55.50% | 15.93% |
| Operating Income | -3.65% | -1.25% | 52.50% | -17.23% | -3.25% |
| Income Before Tax | 27.27% | -0.95% | 61.62% | 46.56% | -11.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 27.27% | -0.95% | 61.62% | 46.56% | -11.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -74.36% | 175.96% | 1,525.08% | -4,433.59% | 761.68% |
| Net Income | 21.78% | 1.21% | 147.45% | -28.94% | -1.32% |
| EBIT | -3.65% | -1.25% | 52.50% | -17.23% | -3.25% |
| EBITDA | -8.48% | -2.77% | 52.94% | -13.35% | 1.52% |
| EPS Basic | 54.48% | 41.65% | 125.98% | 22.58% | 43.67% |
| Normalized Basic EPS | 52.12% | 40.55% | 158.80% | -15.01% | 49.75% |
| EPS Diluted | 54.48% | 41.65% | 125.98% | 22.58% | 43.67% |
| Normalized Diluted EPS | 52.12% | 40.55% | 158.80% | -15.01% | 49.75% |
| Average Basic Shares Outstanding | 71.76% | 69.59% | 82.72% | 66.50% | 79.84% |
| Average Diluted Shares Outstanding | 71.76% | 69.59% | 82.72% | 66.50% | 79.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |